Author:
Cai Yuli,Zhang Jingliao,Yi Meihui,Zhang Wenfeng,Liu Xiaoming,Zhang Xiaoyan,Wan Yang,Chang Lixian,Zhang Li,Chen Xiaojuan,Guo Ye,Zou Yao,Chen Yumei,Li Jun,Zhang Yingchi,Yang Wenyu,Zhu Xiaofan
Funder
Ministry of Science and Technology of China grant
Medical science and Health Technology Innovation Project of Chinese Academy of Medical Sciences
National Natural Science Foundation of China
Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Niemeyer CM, Arico M, Basso G, et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood. 1997;89:3534–43.
2. Stieglitz E, Mazor T, Olshen AB, et al. Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia. Nat Commun. 2017;8:2127.
3. Lipka DB, Witte T, Toth R, et al. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Nat Commun. 2017;8:2126.
4. Furlan I, Batz C, Flotho C, et al. Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7. Blood. 2009;113:2867–8.
5. Cseh A, Niemeyer CM, Yoshimi A, et al. Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood. 2015;125:2311–3.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献